Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Khurram Jamil currently holds 48,750 shares of GALECTIN THERAPEUTICS INC (GALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Khurram Jamil has been a net seller of GALT stock. They have purchased $0 and sold $917.5K worth of shares.
Khurram Jamil's most recent insider trade was on Jul 14, 2026, when they sold 16,250 shares at $0.00 per share.
Khurram Jamil serves as Executive at GALECTIN THERAPEUTICS INC (GALT). They have executed 24 insider transactions totaling $917.5K over their tenure at the company.
Khurram Jamil holds the position of Executive at GALECTIN THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Khurram Jamil has shown a selling trading pattern, with $0 in total purchases and $917.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Khurram Jamil was on Nov 13, 2025, when they sold $227.0K worth of GALT shares. This transaction involved 41,500 shares at $5.47 per share.
Khurram Jamil currently owns 48,750 shares of GALECTIN THERAPEUTICS INC (GALT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Khurram Jamil's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Khurram Jamil has 24 Form 4 filings on record as an insider at GALECTIN THERAPEUTICS INC.
Set alerts for Khurram Jamil and 40,000+ other insiders.